Objective: To obtain a formulation with high bioavailability through evaluation of the stability of three types of Xuesaitong capsules in the stomachs and intestines of rats. We compared the stability of the Panax notoginsenoside R 1 as well as the ginsenosides Rg 1 , Rb 1 , Re, and Rd in different formulations. Methods: Artificial stomach fluid (ASF) and artificial intestinal fluid (AIF) were prepared. Stability of three types of Xuesaitong capsules was examined for 4 h in stomachs and 24 h in intestines. Samples were analyzed at different times by high-performance liquid chromatography. Percent content of NGR 1 , GRg 1 , GRb 1 , GRe, and GRd at different times was calculated. Results: Hard capsules incubated in ASF disintegrated within 2e3 min, whereas soft capsules disintegrated within 7e8 min. Components in hard capsules were dissolved rapidly in water, with content of each compound reaching 90% in 5 min, and degradation of each compound reaching 30e50% after incubation for 240 min. Dissolution and degradation of each component in soft capsules with a water-soluble base tended to balance at 30 e90 min. Contents in soft capsules with a lipid-soluble base showed slow dissolution after ASF incubation for 120 min. Five saponins in identical types of capsules incubated in ASF had similar stability curves. Contents of hard capsules and soft capsules with a watersoluble base degraded rapidly within 30 min and reached a plateau when Xuesaitong capsules were incubated in AIF.
Introduction
Xuesaitong is a traditional Chinese herbal formula in capsule form used to promote blood circulation and dilate blood vessels. As such, in China, the formula is used for the treatment of coronary heart disease, angina, stroke, paralysis and other cardiovascular/cerebrovascular diseases. Studies have shown that Xuesaitong capsules can reduce platelet aggregation, increase blood flow, improve hemodynamics, 1 improve neurologic deficiency 2,3 and improve symptoms of coronary heart disease and angina. 4 Main active components of Xuesaitong formula are Panax notoginseng saponins (PNS). Protopanaxatriol-type saponins such as NGR 1 , GRg 1 , and GRe can be metabolized to protopanaxatriol, which is absorbed into blood via oral administration. Our previous studies showed differences in peak blood concentrations of protopanaxatriol for three types of Xuesaitong capsules after oral administration in beagle dogs. Protopanaxadiol-type saponins GRb 1 and GRd were absorbed poorly through oral administration, 5 and the absolute bioavailability of GRb 1 was only 0.26%. Oral dosage forms of PNS can be metabolized by enzymes and intestinal flora.
We examined the stability of three types of Xuesaitong capsules incubated in the stomachs and intestines of rats. We compared the stability of NGR 1 , GRg 1 , GRb 1 , GRe, and GRd in different formulations to obtain a formulation with high bioavailability.
Materials and methods

Materials
The PNS R1, the ginsenosides Rg 1 , GRg 1 , Rb 1 , Re, and Rd, and standards were obtained from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Sodium chloride was purchased from Beijing Chemical Reagents (Beijing, China). Pepsase and trypsase were obtained from Cytoskeleton (Denver, CO, USA). High-performance liquid chromatography (HPLC)grade acetonitrile was from MREDA Technology (Beijing, China). Ultrapure water was generated from a Synergy ultraviolet water-purification system (Millipore, Billerica, MA, USA). Xuesaitong capsules (batch number: 20111023) were obtained from Yunnan Weihe Pharmaceuticals (Yunnan, China). Xuesaitong soft capsules (batch number: 20121017 163) were purchased from Kunming Flame Pharmaceuticals (Kunming, China), as were Xuesaitong soft capsules with a batch number of 13109-10.
Animals
Male SpragueeDawley rats (220e250 g) were purchased from Vital River Laboratories (Beijing, China). Rats were fasted for 24 h but had unlimited access to water before experimentation.
Animal experiments were undertaken in accordance with the Guidelines for the Care and Use of Laboratory Animals (US National Institutes of Health, Bethesda, MD, USA). The study protocol was approved by the Animal Experimentation Committee of the Beijing University of Chinese Medicine (Beijing, China).
Method validation
HPLC conditions PNS were analyzed by HPLC using a Extend-C18 column (4.6 mm Â 250 mm, 5 mm; Agilent Technologies, Santa Clara, CA, USA) and a pre-column (WATCH Y164; Agilent Technologies) with ultraviolet detection (l Z 203 nm). The mobile phase was acetonitrile and water and eluted according to values shown in Table 1 . The mobile phase was pumped at 1.5 mL/min at 37 C, and the injection volume was 20 mL. 
Linearity
The mixed standard solution was diluted to six concentrations. The standard solution was used according to the chromatographic conditions shown in section 2.2.1 and 20 mL injected. Linear regression by peak area (Y) of the mass concentration of the sample (mg/L) was obtained. The regression equation of each component is shown in Table 2 .
Precision and accuracy
Intra-day precision and accuracy of the method were determined by analyzing six replicates at a specific concentration and a relative standard deviation <3%.
Stability of capsules in rat stomachs
Preparation of a solution of rat stomach contents Rats were fasted for 24 h but had unlimited access to water before experimentation. Rats were narcotized with 20% ethyl carbamate. A small incision (3 cm) was made in the abdomen. A small incision was made in the bottom of the stomach. A silicone tube was inserted and fixed. The stomach was lavaged with 15 mL of artificial gastric fluid (dilute hydrochloric acid, 8.2 mL; 400 mL of water; pepsin, 5 g) at 37 C using a syringe. The effluent was collected and water added to make up to 500 mL. This procedure was repeated five times. Three lavages of rat-stomach contents were collected together (z45 mL), and artificial gastric fluid added to make up to 50 mL.
Incubation of artificial stomach fluid
Two grams of soft capsules with a lipid-soluble base, 1 g of soft capsules with a water-soluble base, and 1 g of hard capsule were added in three conical flasks. The solution of rat stomach contents (50 mL) was added to each flask and incubated in a 37 C shaking incubator at 150 rpm. Aliquots (1 mL) were taken at 1, 5, 15, 30, 60, 90, 120, and 240 min for hard capsules, and at 3, 10, 15, 30, 60, 90, 120, and 240 min for soft capsules. The same volume of a fresh, prewarmed solution of artificial stomach fluid was added to keep the volume constant. The disintegration time was recorded. To each sample was added 450 mL NaOH (0.1 mol/mL) to neutralize gastric acid and terminate the reaction. Supernatants were analyzed for content by HPLC.
Stability of capsules in intestines
Preparation of artificial intestinal fluid Rats were fasted for 24 h but had unlimited access to water before experimentation. Rats were anesthetized with 20% ethyl carbamate. A small incision (3 cm) was made in the abdomen. A small incision was made in the bottom of the ileum. A silicone tube was inserted and fixed. Intestines were lavaged with 40 mL artificial intestinal fluid (monopotassium phosphate, 6.8 g; 500 mL water; adjust the pH to 6.8 with 0.1 mol/L sodium; pancreatic enzymes, 5 g) at 37 C using a syringe. The effluent was collected and water added to make up to 1 L. This procedure was repeated five times. Three lavages of rat-intestine contents were collected together (w45 mL) and artificial intestinal fluid added to make up to 50 mL. 
Incubation in artificial intestinal fluid
Two grams of soft capsules with a lipid-soluble base, 1 g of soft capsules with a water-soluble base, and 1 g of hard capsules were added to three conical flasks. Rat intestinal contents (50 mL) were added to each flask followed by incubation in a 37 C shaking incubator at 150 rpm. Aliquots (1 mL) were taken at 5, 15, 30, 60, 90, 120, 240, 360, 480, 720, 1080, and 1440 min. An identical volume of fresh, prewarmed solution of artificial intestinal fluid was added to keep the volume constant. Supernatants were analyzed for content by HPLC.
Data and statistical analyses
Drug accumulation in the solution of rat-stomach contents was calculated using Eq. (1).
where Qn is the drug accumulation, C n is the concentration of n point (mg/mL),C i is the concentration of the i point (I n À 1). Drug accumulation in the solution of rat intestinal contents was calculated using Eq. (2).
where Qn is the drug accumulation, C n is the concentration of the n point (mg/mL) and C i is the concentration of the i point (I n À 1).
Results
We chose different times of sampling because of the time soft capsules and hard capsules rupture. In the solution of rat stomach contents, hard capsules disintegrated rapidly and ingredients were dissolved in 2e3 min, whereas the two types of soft capsules disintegrated at 7e8 min (Table  3) .
PNSs have poor stability in acid media and degrade rapidly. 5 In artificial stomach fluid, in the three types of capsules, contents of five saponins increased initially and then decreased, thereby embodying dissolutionedegradation (Tables 4e6). Soft capsules with a lipid-soluble base dissolved slowly, the contents of five saponins reached a maximum at 60 min, and then a balance in the dissolution and degradation of each component was reached (Table 4 ). After soft capsules with a water-soluble base disintegrated, dissolution of the contents of five saponins reached a maximum at 30 min; after 120 min, degradation of each component reached a plateau. Hard capsules disintegrated rapidly, dissolution of each component reached a maximum at 5 min, and then each component was degraded in artificial stomach fluid.
Contents of five saponins in identical capsules had similar stability curves in artificial stomach fluid (Fig. 1 ). Various components of hard capsules were degraded after rapid dissolution, and percent content of the ginsenoside Re reached 90% at 5 min. Because of gastric acid and related enzymes, the reaction rate of each compound was different, which caused differences in the degradation of each compound. The ginsenoside Rd degraded most slowly, followed by the ginsenoside Rb 1 . The five saponin constituents in the soft capsule with a lipid-soluble base dissolved slowly and percent content increased slowly over time, taking 120 min to reach a plateau. Each constituent of the soft capsule with a water-soluble base showed dissolution at 30 min, and dissolutionedegradation reached a balance at 30e60 min (Table 7) .
When the three types of capsules were incubated in artificial stomach fluid, the percent content of five saponins in hard capsules were higher than those in soft capsules with a water-soluble base and soft capsules with a lipid-soluble base at 60 min. The content of each component in hard capsules and soft capsules with a lipidsoluble base had similar percent content after 240 min of incubation. Compared with hard capsules, soft capsules disintegrated more slowly. Because of the lipid-soluble base, each component dissolved slower than soft capsules with a water-soluble base, and the lipid base tended to float on the upper part of the fluid (which reduced the content of all compounds in artificial stomach fluid) (Fig. 2) . Just like capsules incubated in artificial stomach fluid, PNS were degraded in artificial intestinal fluid because of enzymes. Contents of hard and soft capsules with a lipidsoluble base incubated in artificial intestinal fluid led to rapid degradation of PNS at 30 min, with each component showing a linear decrease. Contents of soft capsules with a lipid-soluble base incubated in artificial intestinal fluid decreased after an initial increase before reaching a plateau.
Contents of hard and soft capsules with a water-soluble base dissolved rapidly in the solution of rat intestinal contents and then degraded quickly. Because of intestinal enzymes, the reaction rate of each compound differed, which led to differences in the degradation of each component, but all reached a plateau at w30 min. Contents of soft capsules with a lipid-soluble base tended to float in the upper part of the solution of rat intestinal contents. This phenomenon reduced the dissolution rate of all compounds, and all components were dissolved completely at 6 h and then showed degradation (Fig. 3) . Constituents of five saponins in identical capsules had similar metabolism after 24 h of incubation in the solution of rat intestinal contents. Compounds in soft capsules with a lipid-soluble base were suspended in the oil phase and dissolved slowly.
Degradation curves of five saponins in hard and soft capsules with a water-soluble base incubated in the solution of artificial intestinal fluid were similar (Fig. 4) . Percent content of ginsenoside Rb 1 and ginsenoside Rd of soft capsules with a lipid-soluble base was higher than that of hard and soft capsules with a water-soluble base when incubated for 60 min. Percent content of Panax notoginsenoside R1, ginsenoside Rg 1 and ginsenoside Re was basically identical when the three types of capsules were incubated in artificial intestinal fluid for 24 h.
Discussion
We examined the stability of Panax notoginsenoside R 1 as well as the ginsenosides Rg 1 , Re, Rb 1 and Rd in three types of Xuesaitong capsules incubated in artificial stomach fluid and artificial intestinal fluid.
Five types of saponins in three types of capsules incubated in artificial stomach fluid manifested dissolution and degradation. Hard capsules disintegrated faster, with rapid dissolution of components followed by degradation. Soft capsules with a water-soluble base disintegrated at z7e8 min, and dissolution and degradation reached a balance at 30e90 min. Compounds in soft capsules with a lipid-soluble base dispersed in the oil phase and dissolved slowly. Each compound tended to reach a plateau after 120 min of incubation. When incubated in the solution of artificial intestinal fluid, contents of hard and soft capsules with a water-soluble base were degraded rapidly. Compounds of soft capsules with a lipid-soluble base dissolved slowly and then degraded ( Table 8 ).
In the human body, secretion of gastric juice, intestinal juice, and enzymes occurs. Hard capsules and soft capsules with a water-soluble base in the stomach were affected mainly by changes in levels of gastric acid and enzymes. Degradation in the intestines is influenced mainly by enzyme secretion.
Compounds in soft capsules with a lipid-soluble base were affected less by digestive juices, so degradation was lower than that observed in hard and soft capsules with a water-soluble base. In vivo experiments have shown that PNS have poor bioavailability. 6 Also, levels of ginsenosides measured in Caco-2 monolayers have suggested that the membrane permeability of most ginsenosides is poor, with Papp values <3 Â 10 À6 . 7 A possible mechanism may be that PNS have low compatibility with cell membranes. Oil-phase matrices are more likely to promote drug absorption, so soft capsules with a lipid-soluble base may have higher bioavailability.
PNS are the main components of Xuesaitong capsules. The latter have various pharmacologic effects, including anti-thrombus formation, promotion of the growth of hematopoietic cells, circulation of cerebral blood flow, and myocardial protection. 8, 9 PNS R 1 as well as ginsenosides Rg 1 , Re, Rb 1 , and Rd account for z80% of PNS. 10 It has been reported that notoginseng saponin R 1 , ginsenoside Rg 1 and ginsenoside Rb 1 are unstable in acid media. We also found that PNS were degraded in the solution of artificial stomach fluid, a finding that is in accordance with other reports. 11 The greatest difference was in the incubation of hard capsules. Because of the oil-phase matrix, each compound in a soft capsule with a lipid-soluble base reached a dissolutionedegradation balance after 90 min, and percent content remained unchanged during incubation in artificial stomach fluid. All five saponins incubated in the solution of artificial intestinal fluid were degraded, and were affected mainly by enzymes and intestinal flora. The oil-phase matrix of soft capsules with a lipid-soluble base could avoid degradation to a certain degree, thereby showing a sustained-release effect. In summary, compared with hard and soft capsules with a watersoluble base, soft capsules with a lipid-soluble base had better bioavailability. 
